透明质酸酶敏感纳米药物替诺福韦释放动力学建模:一种确定性方法

Q2 Pharmacology, Toxicology and Pharmaceutics
Coulibaly S. Fohona , Vivek Agrahari , Naveen K. Vaidya , Bi-Botti C. Youan
{"title":"透明质酸酶敏感纳米药物替诺福韦释放动力学建模:一种确定性方法","authors":"Coulibaly S. Fohona ,&nbsp;Vivek Agrahari ,&nbsp;Naveen K. Vaidya ,&nbsp;Bi-Botti C. Youan","doi":"10.1016/j.onano.2023.100167","DOIUrl":null,"url":null,"abstract":"<div><p>Despite being convenient and practical, current nanomedicine (NM) release kinetic models remain unscalable, non-specific and less descriptive of the underlying physicochemical determinants. However, a deterministic mathematical modelling could overcome these limitations. In this study, we develop a model, based on a system of two differential equations (accounting for nanoparticle (NP) degradation and then drug release from degraded NM), which enable us to estimate per capita rate constant α (#NP degraded/hr) and β (Drug Amount Released/NP), the net effect of the nanomedicine (NE factor ɣ= α.β) and the controlled release index (φ, ratio of drug release to NP degradation). The model analysis conducted with tenofovir loaded hyaluronidase sensitive NM clearly shows the α factor significantly increased with triggering stimuli due to its enzymatic action on its substrate (hyaluronic acid). However, the β factor remained relatively unchanged, due to intrinsic physicochemical properties of the drug as limiting factor. The application of the solutions of this model clearly enabled us to effectively screen among various nanoformulations and identified the best hyaluronidase-sensitive NM formulation, exhibiting the highest ratio (3.7-fold increase compared to no enzyme). The φ value confirmed the controlled release and stimuli sensitivity of the nanosystem. Moreover, the computed drug release rate (dM/dt) is consistent with other existing mathematical models (under valid assumption). The key advantages of this approach are i) relevancy to underlying physicochemical and biochemical process, ii) versatility and application to various NM kinetics, and iii) prediction of temporo-spatial distribution of the drug loaded NP that could potentially improve <em>in-vitro/in vivo</em> correlation study. This unique approach is applicable for a more specific and more meaningful/physicochemically relevant description of bioactive agents release from NM or NP for various applications.</p></div>","PeriodicalId":37785,"journal":{"name":"OpenNano","volume":"13 ","pages":"Article 100167"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Modelling tenofovir release kinetics from hyaluronidase-sensitive nanomedicine: A deterministic approach\",\"authors\":\"Coulibaly S. Fohona ,&nbsp;Vivek Agrahari ,&nbsp;Naveen K. Vaidya ,&nbsp;Bi-Botti C. Youan\",\"doi\":\"10.1016/j.onano.2023.100167\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Despite being convenient and practical, current nanomedicine (NM) release kinetic models remain unscalable, non-specific and less descriptive of the underlying physicochemical determinants. However, a deterministic mathematical modelling could overcome these limitations. In this study, we develop a model, based on a system of two differential equations (accounting for nanoparticle (NP) degradation and then drug release from degraded NM), which enable us to estimate per capita rate constant α (#NP degraded/hr) and β (Drug Amount Released/NP), the net effect of the nanomedicine (NE factor ɣ= α.β) and the controlled release index (φ, ratio of drug release to NP degradation). The model analysis conducted with tenofovir loaded hyaluronidase sensitive NM clearly shows the α factor significantly increased with triggering stimuli due to its enzymatic action on its substrate (hyaluronic acid). However, the β factor remained relatively unchanged, due to intrinsic physicochemical properties of the drug as limiting factor. The application of the solutions of this model clearly enabled us to effectively screen among various nanoformulations and identified the best hyaluronidase-sensitive NM formulation, exhibiting the highest ratio (3.7-fold increase compared to no enzyme). The φ value confirmed the controlled release and stimuli sensitivity of the nanosystem. Moreover, the computed drug release rate (dM/dt) is consistent with other existing mathematical models (under valid assumption). The key advantages of this approach are i) relevancy to underlying physicochemical and biochemical process, ii) versatility and application to various NM kinetics, and iii) prediction of temporo-spatial distribution of the drug loaded NP that could potentially improve <em>in-vitro/in vivo</em> correlation study. This unique approach is applicable for a more specific and more meaningful/physicochemically relevant description of bioactive agents release from NM or NP for various applications.</p></div>\",\"PeriodicalId\":37785,\"journal\":{\"name\":\"OpenNano\",\"volume\":\"13 \",\"pages\":\"Article 100167\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"OpenNano\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2352952023000464\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"OpenNano","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352952023000464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

尽管方便实用,但目前的纳米药物释放动力学模型仍然不可扩展,非特异性和对潜在物理化学决定因素的描述较少。然而,一个确定性的数学模型可以克服这些限制。在这项研究中,我们建立了一个基于两个微分方程系统的模型(考虑纳米颗粒(NP)的降解,然后从降解的纳米颗粒中释放药物),使我们能够估计人均速率常数α (#NP降解/小时)和β(药物释放量/NP),纳米药物的净效应(NE因子α = α.β)和控释指数(φ,药物释放与NP降解的比率)。用负载替诺福韦的透明质酸酶敏感NM进行的模型分析清楚地表明,由于α因子对其底物(透明质酸)的酶促作用,α因子在触发刺激下显着增加。由于药物本身的理化性质是限制因子,β因子保持相对不变。该模型的应用使我们能够有效地筛选各种纳米配方,并确定了最佳的透明质酸酶敏感纳米配方,其比例最高(与无酶相比增加3.7倍)。φ值证实了纳米系统的控释和刺激敏感性。此外,计算的药物释放率(dM/dt)与其他现有的数学模型(在有效假设下)是一致的。该方法的主要优点是1)与潜在的物理化学和生化过程相关,2)通用性和应用于各种纳米动力学,3)预测载药NP的时空分布,可能改善体外/体内相关性研究。这种独特的方法适用于更具体和更有意义/物理化学相关的描述生物活性药物从NM或NP释放的各种应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Modelling tenofovir release kinetics from hyaluronidase-sensitive nanomedicine: A deterministic approach

Modelling tenofovir release kinetics from hyaluronidase-sensitive nanomedicine: A deterministic approach

Despite being convenient and practical, current nanomedicine (NM) release kinetic models remain unscalable, non-specific and less descriptive of the underlying physicochemical determinants. However, a deterministic mathematical modelling could overcome these limitations. In this study, we develop a model, based on a system of two differential equations (accounting for nanoparticle (NP) degradation and then drug release from degraded NM), which enable us to estimate per capita rate constant α (#NP degraded/hr) and β (Drug Amount Released/NP), the net effect of the nanomedicine (NE factor ɣ= α.β) and the controlled release index (φ, ratio of drug release to NP degradation). The model analysis conducted with tenofovir loaded hyaluronidase sensitive NM clearly shows the α factor significantly increased with triggering stimuli due to its enzymatic action on its substrate (hyaluronic acid). However, the β factor remained relatively unchanged, due to intrinsic physicochemical properties of the drug as limiting factor. The application of the solutions of this model clearly enabled us to effectively screen among various nanoformulations and identified the best hyaluronidase-sensitive NM formulation, exhibiting the highest ratio (3.7-fold increase compared to no enzyme). The φ value confirmed the controlled release and stimuli sensitivity of the nanosystem. Moreover, the computed drug release rate (dM/dt) is consistent with other existing mathematical models (under valid assumption). The key advantages of this approach are i) relevancy to underlying physicochemical and biochemical process, ii) versatility and application to various NM kinetics, and iii) prediction of temporo-spatial distribution of the drug loaded NP that could potentially improve in-vitro/in vivo correlation study. This unique approach is applicable for a more specific and more meaningful/physicochemically relevant description of bioactive agents release from NM or NP for various applications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
OpenNano
OpenNano Medicine-Pharmacology (medical)
CiteScore
4.10
自引率
0.00%
发文量
63
审稿时长
50 days
期刊介绍: OpenNano is an internationally peer-reviewed and open access journal publishing high-quality review articles and original research papers on the burgeoning area of nanopharmaceutics and nanosized delivery systems for drugs, genes, and imaging agents. The Journal publishes basic, translational and clinical research as well as methodological papers and aims to bring together chemists, biochemists, cell biologists, material scientists, pharmaceutical scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信